▲ BUY
10
/ 10
Conviction
$ Value
$3K
Shares
1,000
Price
$3
Filed
Jul 21
▶ Why this score? (10/10)
- ✓ Open market buy (+3)
- ✓ % of holdings >= 20% (+2)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ 10%+ owner (+1)
- ✓ Cluster: 3 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Leheny A. Rachel
Title
CHIEF EXECUTIVE OFFICER
CIK
0001484729
Roles
Director
Officer
10% Owner
Transaction Details
Transaction Date
2025-07-21
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
3,500
Filing Info
Leheny A. Rachel's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-21 | CALC | ▲ | $3K |
| 2025-07-14 | CALC | ▲ | $6K ★ |
| 2025-06-24 | CALC | A | $0 |
| 2025-04-23 | CALC | A | $0 |
| 2025-04-05 | CALC | A | $0 |
Other Insiders at CALC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER
|
— | — | 2025-04-05 |
|
Roberts Eric W
CHIEF BUSINESS OFFICER
|
— | — | 2025-04-05 |
|
Bardin Stephen
Chief Financial Officer
|
— | — | 2025-04-05 |
|
Dunn Michael J.
President and COO
|
— | — | 2025-04-05 |
|
Hebbar Sudarshan
Chief Medical Officer
|
— | — | 2025-04-05 |
|
Stauderman Kenneth A.
Chief Scientific Officer
|
— | — | 2025-04-05 |